|
1
|
McMurray JJ and Pfeffer MA: Heart failure.
Lancet. 365:1877–1889. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Charlson FJ, Erskine HE, Ferrari AJ, Leung
J, Whiteford HA, Abajobir AA, Knibbs LD, Lalloo R, Scott JG and Guo
Y; GBD 2015 Disease and Injury Incidence and Prevalence
Collaborators, : Global, regional, and national incidence,
prevalence, and years lived with disability for 310 diseases and
injuries, 1990–2015: A systematic analysis for the Global Burden of
Disease Study 2015. Lancet. 388:1545–1602. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee, : Executive summary: heart disease and
stroke statistics - 2013 update: a report from the American Heart
Association. Circulation. 127:143–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kusumoto A, Miyata M, Kubozono T, Ikeda Y,
Shinsato T, Kuwahata S, Fujita S, Takasaki K, Yuasa T, Hamasaki S,
et al: Highly sensitive cardiac troponin T in heart failure:
Comparison with echocardiographic parameters and natriuretic
peptides. J Cardiol. 59:202–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Gesualdo F, Capaccioli S and Lulli M: A
pathophysiological view of the long non-coding RNA world.
Oncotarget. 5:10976–10996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao W, Luo J and Jiao S: Comprehensive
characterization of cancer subtype associated long non-coding RNAs
and their clinical implications. Sci Rep. 4:65912014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gomes da Silva AM and Silbiger VN: miRNAs
as biomarkers of atrial fibrillation. Biomarkers. 19:631–636. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, et al: The lncRNA H19
promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Papait R, Kunderfranco P, Stirparo GG,
Latronico MVG and Condorelli G: Long noncoding RNA: A new player of
heart failure? J Cardiovasc Transl Res. 6:876–883. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han P, Li W, Lin CH, Yang J, Shang C,
Nuernberg ST, Jin KK, Xu W, Lin CY, Lin CJ, et al: A long noncoding
RNA protects the heart from pathological hypertrophy. Nature.
514:102–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi X, Xu Y, Zhang C, Feng L, Sun Z, Han
J, Su F, Zhang Y, Li C and Li X: Subpathway-LNCE: Identify
dysfunctional subpathways competitively regulated by lncRNAs
through integrating lncRNA-mRNA expression profile and pathway
topologies. Oncotarget. 7:69857–69870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Han J, Yao Q, Zou C, Xu Y, Zhang C,
Shang D, Zhou L, Zou C, Sun Z, et al: Subpathway-GM: Identification
of metabolic subpathways via joint power of interesting genes and
metabolites and their topologies within pathways. Nucleic Acids
Res. 41:e1012013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Shen L, Shang X and Liu W:
Subpathway analysis based on signaling-pathway impact analysis of
signaling pathway. PLoS One. 10:e01328132015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greco S, Fasanaro P, Castelvecchio S,
D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC,
Menicanti L and Martelli F: MicroRNA dysregulation in diabetic
ischemic heart failure patients. Diabetes. 61:1633–1641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HB, Jiang ZB and Li M: Research on
the typical miRNA and target genes in squamous cell carcinoma and
adenocarcinoma of esophagus cancer with DNA microarray. Pathol
Oncol Res. 20:245–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nahler G: Pearson correlation coefficient.
Dictionary of Pharmaceutical Medicine. Springer-Verlag Vienna;
Austria: pp. 1322009, View Article : Google Scholar
|
|
19
|
Best DJ and Roberts DE: Algorithm AS 89:
The upper tail probabilities of Spearman's Rho. Appl Stat.
24:377–379. 1975. View
Article : Google Scholar
|
|
20
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T,
et al: KEGG for linking genomes to life and the environment.
Nucleic Acids Res. 36:D480–D484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
22
|
Epstein MP, Duncan R, Jiang Y, Conneely
KN, Allen AS and Satten GA: A permutation procedure to correct for
confounders in case-control studies, including tests of rare
variation. Am J Hum Genet. 91:215–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Molkentin JD and Dorn GW II: Cytoplasmic
signaling pathways that regulate cardiac hypertrophy. Annu Rev
Physiol. 63:391–426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim ES, Kim MS and Moon A:
TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38
MAPK, but not ERK signaling in MCF10A human breast epithelial
cells. Int J Oncol. 25:1375–1382. 2004.PubMed/NCBI
|
|
25
|
Qiu Q, Yang M, Tsang BK and Gruslin A:
EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves
activation of both PI3K and MAPK signalling pathways. Reproduction.
128:355–363. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ulke-Lemée A, Trinkle-Mulcahy L, Chaulk S,
Bernstein NK, Morrice N, Glover M, Lamond AI and Moorhead GBG: The
nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside
kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G.
Biochim Biophys Acta. 1774:1339–1350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Armstrong L, Lako M, van Herpe I, Evans J,
Saretzki G and Hole N: A role for nucleoprotein Zap3 in the
reduction of telomerase activity during embryonic stem cell
differentiation. Mech Dev. 121:1509–1522. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leri A, Franco S, Zacheo A, Barlucchi L,
Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P and
Blasco MA: Ablation of telomerase and telomere loss leads to
cardiac dilatation and heart failure associated with p53
upregulation. EMBO J. 22:131–139. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shiojima I and Walsh K: Regulation of
cardiac growth and coronary angiogenesis by the Akt/PKB signaling
pathway. Genes Dev. 20:3347–3365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chaanine AH and Hajjar RJ: AKT signalling
in the failing heart. Eur J Heart Fail. 13:825–829. 2011.
View Article : Google Scholar : PubMed/NCBI
|
